Definitive Contract 75N91019C00027
Award Date
9/11/19
Potential Completion Date
11/15/20
Potential Value
$225K
Federal Agency
National Cancer Institute
Awardee
Dimagi Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
95
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by a U.S. government agency to Dimagi Inc., a global social enterprise based in Cambridge, Massachusetts that develops digital health solutions and data collection software. The $99,964.00 contract, awarded on September 1, 2006 with a completion date of April 30, 2007, is for the development of "A SYSTEM TO COORDINATE AND TRACK HOME BASED CHRONIC CARE IN PATIENTS WITH CANCER." Dimagi, a self-certified small...
This is a $867,688.86 federal contract awarded by the National Cancer Institute (NCI) to Dimagi Inc., a global social enterprise that develops digital health solutions and data collection software. The contract is a Small Business Innovation Research (SBIR) Phase II award for the development of a system to coordinate and track home-based chronic care for cancer patients. Dimagi, a self-certified small disadvantaged business, is the prime contractor on this cost-plus-fixed-fee definitive...
This SBIR Phase I contract was awarded by the National Institutes of Health National Cancer Institute to Outcomes4Me Inc. for $452,514. The contract is for the period of September 16, 2020 through September 15, 2022 and involves developing mobile health technology to utilize cancer survivorship navigation for patient benefit. The solicitation sought proposals to conduct research and development in support of NIH and CDC agency missions, including topics related to cancer immunotherapy...
This SBIR Phase I contract from the National Cancer Institute, valued at $361,254, was awarded to Avident Health LLC. The firm will develop its MyNavigator mHealth application for use in patient navigator breast cancer care workflows, as requested under NIH Solicitation 406. This total small business set-aside solicitation sought proposals for Phase I and Phase II SBIR contracts to conduct R&D supporting NIH and CDC agency missions, including alternatives to cell culture materials and cancer...
This $399,987 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to Care Progress LLC, a small business limited liability company. The contract supports the development of cancer clinical trials recruitment and retention tools for participant engagement, as described in the original SBIR solicitation. The solicitation sought proposals for SBIR Phase I and Phase II contracts to conduct...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), an institute of the National Institutes of Health (NIH), to Lucidact Inc., a minority-owned and disadvantaged small business located in Los Angeles, CA. The $454,524 fixed-price contract is for the development of a digital tool to integrate cancer prevention within primary care, as part of the broader SBIR program objectives to stimulate technological innovation and strengthen the...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $274,984.00 Firm Fixed Price Phase I Small Business Innovation Research (SBIR) contract to Brightoutcome Inc., a small disadvantaged business, for the project "CONNECTING CANCER CAREGIVERS TO CARE TEAMS: DIGITAL PLATFORMS TO SUPPORT INFORMAL CANCER CAREGIVING". The contract, which was set aside for small businesses, aims to develop digital platforms to support informal cancer...
This is a $399,992 firm fixed price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Xanthoshealth, Inc., a small business concern, to develop "Software to Address Social Determinants of Health in Oncology Practices" under the NCI's SBIR program. The original solicitation sought proposals for innovative research across various biomedical and public health topics, including digital health tools, to contribute towards the NCI and Centers for Disease Control and...
This SBIR Phase I contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Navipoint Genomics LLC, a minority-owned and Asian-Pacific American-owned limited liability company. The $251,927 firm-fixed-price contract is for the development of cloud-based software in support of the Cancer Research Data Commons. This contract was issued under the total small business set-aside NIH SBIR solicitation PHS-2020-1, which...
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded a $453,123 Small Business Innovation Research (SBIR) Phase I contract to Pistevo Decision LLC, a minority-owned small business, to develop an integrated multi-level decision support platform to address patient-centered and evidence-based social determinants of health among cancer patients. This Phase I contract is part of a two-year $2 million SBIR Phase II award granted to Pistevo in September 2023....